CHICAGO & ITASCA, Ill.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group's StemFit™ stem cell culture products using Syntax Bio's ...
The world's hunger for artificial-intelligence chips is straining the industry's ability to produce the materials they rely on, creating new pressure points that could slow the boom.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.